Porton Pharma Solutions receives $681M purchase order from Pfizer

Porton Pharma Solutions (Porton) received new purchase orders from Pfizer Ireland Pharmaceuticals, a subsidiary of Pfizer Inc., for contract development and manufacturing (CDMO) services. The total order value is $681 million, exceeding 50% of Porton's most recent audited annual revenue.

“新获得订单金额合计6.81亿美元，超过公司最近一个会计年度经审计营业收入的50%。”beta.zhitongcaijing.com

• 1 source
• beta.zhitongcaijing.com博腾股份(300363.SZ)收到价值6.81亿美元辉瑞采购订单Feb 11, 2022

Summarized from public sources; check the original articles before acting on it.